Mycoplasma, a genus of bacteria is a causative agent for various infectious diseases in humans such as pneumonia and pelvic inflammatory diseases and some mycoplasmic species are also detected in different types of cancer cells. Due to their lack of cell wall, mycoplasmal bacteria are resistant to many common antibiotics which target cell wall synthesis. Mycoplasma organisms are usually associated with mucosal surfaces, residing extracellular in the respiratory and urogenital tracts. Mycoplasma diagnostic testing offers rapid test results providing detection of outbreaks, newly emerging strains; and sensitivity, specificity and identification of resistant organisms, and can help correlate to disease severity. This will facilitate timely therapeutic clinical decisions and early infection control interventions.
Browse Full Report:- http://www.transparencymarketresearch.com/mycoplasma-diagnostics-market.html